Study of low-dose ketamine for sickle cell pain crisis
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital clinical trials.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 20 years old
- You have sickle cell disease (not just trait)
- You are in a pain crisis that needs IV pain medicine
- You speak English or Spanish
- You have not had a bad reaction to ketamine before
- You do not have serious health problems like uncontrolled high blood pressure, heart disease, liver or kidney disease, or certain mental health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of ketamine, a pain medicine, can safely reduce pain during a sickle cell crisis in the emergency department. It aims to provide quicker pain relief for people with sickle cell disease.
This trial looks at the best time to start giving ketamine, a pain-relieving medicine, for sickle cell pain. It aims to find out whether giving it earlier or later in your visit works better and is safer.
This trial tests whether a numbing medicine (lidocaine) given through a vein can help reduce the amount of strong painkillers (morphine or oxycodone) needed for a sickle cell pain crisis or acute chest syndrome. It aims to ease pain and possibly lower side effects from opioids.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.